Dean A. Regier

The Centre for Health (New Zealand) — New Zealand

Economics, Econometrics and Finance · Social Sciences

40h-index9.2kcitations273works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(93), Cancer Genomics and Diagnostics(36), Genomics and Rare Diseases(32), Economic and Financial Impacts of Cancer(30), BRCA gene mutations in cancer(26)

Publications269 total

Care preferences for persons with cognitive impairment: A discrete choice experiment
Alzheimer s & Dementia·2026Open Access
P7 Life-Cycle Economic Modeling to Determine the Evolving Value of a Tumor-Agnostic Precision Oncology Therapy With Conditional Marketing Authorization
Value in Health·2025
EE553 Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis
Value in Health·2025
PCR165 Navigating Uncertainty and Pragmatic Acceptance: Canadian Patient and Public Perspectives on Radiopharmaceutical Therapy in the Context of Whole Health
Value in Health·2025
MSR16 Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models
Value in Health·2025
RWD13 AI for Precision Oncology Evidence: Case Study Research From British Columbia, Canada
Value in Health·2025
Determining the value of genomics in healthcare
Nature Medicine·2025· 2 cited
Patient and population impacts of multigene panel and pembrolizumab coverage in metastatic melanoma
JNCI Journal of the National Cancer Institute·2025Open Access
Developing an Accessible Discrete Choice Survey to Identify Supportive Care Preferences of Older Adults With Dementia
Value in Health·2025· 1 citedOpen Access
How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology
Frontiers in Medicine·2025Open Access
The cost and cost trajectory of genome sequencing and bioinformatics analysis for Indigenous children with suspected rare diseases
Genetics in Medicine·2025
Determining the Survival Impact and Cost‐Effectiveness of Multi‐Gene Panel Sequencing in Metastatic Colorectal Cancer With Super Learning Approaches
Health Services Research·2025
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia
Personalized Medicine·2025
Using a Discrete Choice Experiment to Elicit Patient Preferences for Physical Therapist Services After Surgery for Breast Cancer
Physical Therapy·2025
Concordance of parent-of-origin predictions for hereditary cancer variants using proband-only analysis.
Journal of Clinical Oncology·2025
Effectiveness and Cost-Effectiveness of Gene Panels in Melanoma
2025
Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity
Value in Health·2025· 1 cited
352: PARENT-OF-ORIGIN DETERMINATION OF PATHOGENIC VARIANTS IN HEREDITARY CANCER GENES WITHOUT PARENTAL DATA IN REAL-WORLD SAMPLES
Gastroenterology·2025
Erratum: Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation
JCO Precision Oncology·2025Open Access
Putting the substance in substantial evidence: an evidence-based approach to flexible drug regulation
Frontiers in Medicine·2025· 1 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Deirdre Weymann(7), Deborah A. Marshall(6), Ronald C. Desrosiers(6), Donna E. Akiyoshi(6), Carlo A. Marra(5), M P Gordon(5), Kasmintan A. Schrader(5), Sarah Wordsworth(5), James Buchanan(5), Sophie Sun(4), Stuart Peacock(4), David L. Veenstra(4), John F. P. Bridges(3), James S. Gibbs(3), Eugene W. Nester(3), Stephen Yip(3), Stephen Chia(3), Karen A. Gelmon(3), Howard J. Lim(3), Daniel J. Renouf(3)